With more than 15,000 distinct strains, VITEK® MS provides the microbiology lab with the most comprehensive Mass Spectrometry database to improve clinical decision-making for infectious diseases.
Durham, NC – July 24, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce its 2017 Press Conference at the American Association of Clinical Chemistry: “Antimicrobial Stewardship Empowered by Rapid Diagnostics,” to be held August 2, at 9:00 am (PST) at the San Diego Convention Center.
Marcy l'Étoile (France), July 20, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2017.
The following letter was issued concerning the WannaCry ransomware attack in May 2017. The directions provided to protect your system also apply to the June 2017 Petya ransomware attack.
Please be advised the bioMérieux manufacturing and shipping locations in Durham, NC, St. Louis, MO, Louisville, KY and Lombard, IL will be closed on Tuesday, July 4, 2017 in observance of Independence Day.
The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity
Marcy l'Etoile, France, May 2017 - Media Statement - bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to support the launch of the AMR Industry Alliance, a new alliance to drive and measure industry progress to curb antimicrobial resistance.
With a recently approved blood culture system, new indications for its procalcitonin (PCT) diagnostic assay, and an arsenal of molecular testing tools, bioMérieux is aiming to become a leader in the increasingly competitive field of antibiotic stewardship.
A world leader in the field of in vitro diagnostics for over 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2016, revenues reached €2,103 million, with more than 90% of international sales.
Durham, NC – San Diego, CA (May 10, 2017) – bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce that its U.S. affiliate, bioMérieux Inc. will be expanding its partnership with Sepsis Alliance. bioMérieux Inc. will serve as the 2017 National Sepsis Awareness and Education Title Sponsor, including sponsorship of Sepsis Alliance’s Sepsis Challenge™ events.
